ArticleFrontiers in pharmacology2026

Tumour microenvironment and HER2-low status dictate response and resistance to anthracycline-taxane chemotherapy in premenopausal TNBC: a retrospective multicohort study.

Shuanglong Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.